ARCHIVES

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP During May

June 28, 2002

Chest X-Ray Produces Many False-Positive Results

January 27, 2006

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

Number of Cancer Deaths Rise Slightly Due To Population Growth And Aging.

February 22, 2008

The Tivozanib Timeline

May 10, 2013

CIIT’s Swenberg Denies He Is NTP “Industry Representative”

December 12, 1980